| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; Human papillomavirus; loading ...; fig 6c
| Periyasamy M, Singh A, Gemma C, Kranjec C, Farzan R, Leach D, et al. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells. Nucleic Acids Res. 2017;45:11056-11069 pubmed publisher |
- immunocytochemistry; Human papillomavirus; loading ...; fig 7d
- western blot; Human papillomavirus; 1:500; loading ...; fig 5a
| Zhang X, Hou W, Epperly M, Rigatti L, Wang H, Franicola D, et al. Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures. Oncotarget. 2016;7:68449-68472 pubmed publisher |
- western blot; Human papillomavirus; fig 6
| Zhou N, Yuan S, Wang R, Zhang W, Chen J. Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence. Oncotarget. 2015;6:30745-61 pubmed publisher |
- chromatin immunoprecipitation; human; fig 7
| Chalertpet K, Pakdeechaidan W, Patel V, Mutirangura A, Yanatatsaneejit P. Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation. Cancer Sci. 2015;106:1333-40 pubmed publisher |
- western blot; human; fig 2c
| Li Y, Ma Z, Zhao Y, Zhang J. Immunization with mutant HPV16 E7 protein inhibits the growth of TC-1 cells in tumor-bearing mice. Oncol Lett. 2015;9:1851-1856 pubmed |
- immunocytochemistry; human; loading ...; fig 4
- western blot; human; 1:1000; loading ...; fig 3
| Wu J, Chen K, Gao M, Chen G, Jin S, Zhuang F, et al. Genetic stability of a recombinant adenovirus vaccine vector seed library expressing human papillomavirus type 16 E6 and E7 proteins. Exp Ther Med. 2015;9:1161-1165 pubmed |
| Ding W, Hu Z, Zhu D, Jiang X, Yu L, Wang X, et al. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells. Clin Cancer Res. 2014;20:6495-503 pubmed publisher |
- immunohistochemistry; human; 1:80-1:100
| Chakraborty C, Dutta S, Mukherjee N, Samadder S, Roychowdhury A, Roy A, et al. Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication. Tumour Biol. 2015;36:1143-54 pubmed publisher |
| Pang C, Toh S, He P, Teissier S, Ben Khalifa Y, Xue Y, et al. A functional interaction of E7 with B-Myb-MuvB complex promotes acute cooperative transcriptional activation of both S- and M-phase genes. (129 c). Oncogene. 2014;33:4039-49 pubmed publisher |
| Shankar S, Sreekumar A, Prasad D, Das A, Pillai M. Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design. Cancer Cell Int. 2018;18:169 pubmed publisher |
| Qiao L, Zheng J, Tian Y, Zhang Q, Wang X, Chen J, et al. Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells. Cell Death Dis. 2018;9:583 pubmed publisher |
| Bienkowska Haba M, Luszczek W, Myers J, Keiffer T, DiGiuseppe S, Polk P, et al. A new cell culture model to genetically dissect the complete human papillomavirus life cycle. PLoS Pathog. 2018;14:e1006846 pubmed publisher |
| Westrich J, Warren C, Klausner M, Guo K, Liu C, Santiago M, et al. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation. J Virol. 2018;92: pubmed publisher |
| Kim K, Godarova A, Seedle K, Kim M, Ince T, Wells S, et al. Rb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner. PLoS ONE. 2013;8:e80590 pubmed publisher |
| Benson E, Mungamuri S, Attie O, Kracikova M, Sachidanandam R, Manfredi J, et al. p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes. Oncogene. 2014;33:3959-69 pubmed publisher |
| Debata P, Castellanos M, Fata J, Baggett S, Rajupet S, Szerszen A, et al. A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells. Gynecol Oncol. 2013;129:145-53 pubmed publisher |
| Ribelles P, Benbouziane B, Langella P, Suárez J, Bermúdez Humarán L. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface. Appl Microbiol Biotechnol. 2013;97:1231-9 pubmed publisher |
| Fan X, Liu Y, Heilman S, Chen J. Human papillomavirus E7 induces rereplication in response to DNA damage. J Virol. 2013;87:1200-10 pubmed publisher |
| Milrot E, Jackman A, Kniazhanski T, Gonen P, Flescher E, Sherman L. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin. Cancer Lett. 2012;319:31-8 pubmed publisher |
| van der Watt P, Ngarande E, Leaner V. Overexpression of Kpn?1 and Kpn?2 importin proteins in cancer derives from deregulated E2F activity. PLoS ONE. 2011;6:e27723 pubmed publisher |
| WARD M, van der Watt P, Tzoneva G, Leaner V. Deregulated LAP2? expression in cervical cancer associates with aberrant E2F and p53 activities. IUBMB Life. 2011;63:1018-26 pubmed publisher |
| Deng X, Li W, Zhang X, Wang C, Dong Z, Zhang X, et al. RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells. Int J Gynecol Cancer. 2011;21:28-34 pubmed publisher |
| Luevano M, Bernard H, Barrera Saldaña H, Trevino V, Garcia Carranca A, Villa L, et al. High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology. 2010;405:31-40 pubmed publisher |
| Sulg M, Kirjavainen A, Pajusola K, Bueler H, Ylikoski J, Laiho M, et al. Differential sensitivity of the inner ear sensory cell populations to forced cell cycle re-entry and p53 induction. J Neurochem. 2010;112:1513-26 pubmed publisher |
| Dutta T, Burgess M, McMillan N, Parekh H. Dendrosome-based delivery of siRNA against E6 and E7 oncogenes in cervical cancer. Nanomedicine. 2010;6:463-70 pubmed publisher |
| Bellone S, El Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, et al. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L. J Virol. 2009;83:6779-89 pubmed publisher |
| Li W, Kotoshiba S, Berthet C, Hilton M, Kaldis P. Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition. Proc Natl Acad Sci U S A. 2009;106:486-91 pubmed publisher |
| Li H, Ou X, Xiong J, Wang T. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. Biochem Biophys Res Commun. 2006;349:1315-21 pubmed |
| Fikaris A, Lewis A, Abulaiti A, Tsygankova O, Meinkoth J. Ras triggers ataxia-telangiectasia-mutated and Rad-3-related activation and apoptosis through sustained mitogenic signaling. J Biol Chem. 2006;281:34759-67 pubmed |
| Tang S, Tao M, McCoy J, Zheng Z. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol. 2006;80:4249-63 pubmed |
| Tang S, Tao M, McCoy J, Zheng Z. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene. 2006;25:2094-104 pubmed |
| Lentini L, Iovino F, Amato A, Di Leonardo A. Centrosome amplification induced by hydroxyurea leads to aneuploidy in pRB deficient human and mouse fibroblasts. Cancer Lett. 2006;238:153-60 pubmed |
| Valdespino V, Gorodezky C, Ortiz V, Kaufmann A, Román Basaure E, Vazquez A, et al. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients. Gynecol Oncol. 2005;96:92-102 pubmed |
